DNLI insider transaction filings
Denali Therapeutics Inc. — 29 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-14. Screen DNLI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Watts Ryan J. — President and CEO, Director | Gift (G): 32,220 @ $0 | EDGAR |
| 2026-08-13 | 4 | Schuth Alexander O. — COFO and Secretary | Sale (S): 2,857 @ $25.07 | EDGAR |
| 2026-06-05 | 4 | Van Hauwermeiren Timothy — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Thornberry Nancy — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Cook Jennifer E. — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Krognes Steve E. — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Schenkein David P — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Klein Peter S — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | FLATLEY JAY T — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | BAKER BROS. ADVISORS LP — Director 667, L.P. — Director Baker Bros. Advisors (GP) LLC — Director Baker Brothers Life Sciences LP — Director BAKER FELIX — Director BAKER JULIAN — Director | Grant/award (A): 6,408 @ $0 · Grant/award (A): 6,408 @ $0 · Grant/award (A): 19,226 (derivative) @ $0 · Grant/award (A): 19,226 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | Schuth Alexander O. — COFO and Secretary | Sale (S): 17,218 @ $16.50 | EDGAR |
| 2026-01-08 | 4 | Watts Ryan J. — President and CEO, Director | Sale (S): 35,198 @ $16.50 | EDGAR |
| 2026-01-05 | 4 | Schuth Alexander O. — COFO and Secretary | Grant/award (A): 57,700 @ $0 · Grant/award (A): 173,100 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Watts Ryan J. — President and CEO, Director | Grant/award (A): 78,960 @ $0 · Grant/award (A): 236,880 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | BAKER BROS. ADVISORS LP — Director 667, L.P. — Director Baker Bros. Advisors (GP) LLC — Director Baker Brothers Life Sciences LP — Director BAKER FELIX — Director BAKER JULIAN — Director | Purchase (P): 190,523 (derivative) @ $17.49 · Purchase (P): 2,095,191 (derivative) @ $17.49 | EDGAR |
| 2025-11-06 | 4 | Van Hauwermeiren Timothy — Director | Grant/award (A): 10,632 @ $0 · Grant/award (A): 31,897 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Watts Ryan J. — President and CEO, Director | Gift (G): 50,000 @ $0 | EDGAR |
| 2025-08-14 | 4 | Schuth Alexander O. — COFO and Secretary | Sale (S): 2,937 @ $13.58 | EDGAR |
| 2025-08-14 | 4 | Ho Carole — Chief Medical Officer | Sale (S): 2,937 @ $13.58 · Sale (S): 806 @ $14.64 | EDGAR |
| 2025-08-07 | 4 | Ho Carole — Chief Medical Officer | Option exercise (M): 44,655 @ $0.68 · Option exercise (M): 44,655 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | Watts Ryan J. — President and CEO, Director | Option exercise (M): 455,282 @ $0.68 · Option exercise (M): 40,000 @ $5.28 · Sale (S): 495,282 @ $15 · Option exercise (M): 455,282 (derivative) @ $0 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cook Jennifer E. — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Thornberry Nancy — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Krognes Steve E. — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Schenkein David P — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Klein Peter S — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Tessier-Lavigne Marc — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | FLATLEY JAY T — Director | Grant/award (A): 6,037 @ $0 · Grant/award (A): 18,111 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | BAKER BROS. ADVISORS LP — Director 667, L.P. — Director Baker Bros. Advisors (GP) LLC — Director Baker Brothers Life Sciences LP — Director BAKER FELIX — Director BAKER JULIAN — Director | Grant/award (A): 10,565 @ $0 · Grant/award (A): 10,565 @ $0 · Grant/award (A): 31,695 (derivative) @ $0 · Grant/award (A): 31,695 (derivative) @ $0 | EDGAR |
Recent 8-K events — Denali Therapeutics Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-03-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DNLI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →